Drug Approval Package
Naropin (Ropivacaine HCI)
Injection
Company: AstraZeneca L.P.
Application No.: 020533S002
Approval Date: 11/02/2000
-
Approval Letter(s) (PDF)
-
Printed Labeling (PDF)
-
Medical Review(s)
Part 1 (PDF)
Part 2 (PDF)
Part 3 (PDF)
Part 4 (PDF)
Part 5 (PDF)
Part 6 (PDF) -
Pharmacology Review(s) (PDF)
-
Statistical Review(s) (PDF)
-
Administrative Document(s) & Correspondence
Part 1 (PDF)
Part 2 (PDF)
Date created: June 282004
Note: Documents in PDF format require the Adobe Acrobat Reader®.